These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1698543)

  • 21. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.
    Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM
    Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
    Gutierrez PL; Wilder PJ; Biswal N
    Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
    Muller C; Goubin F; Ferrandis E; Cornil-Scharwtz I; Bailly JD; Bordier C; Bénard J; Sikic BI; Laurent G
    Mol Pharmacol; 1995 Jan; 47(1):51-6. PubMed ID: 7838133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
    Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
    Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells.
    Schmidt-Wolf IG; Lefterova P; Johnston V; Scheffold C; Csipai M; Mehta BA; Tsuruo T; Huhn D; Negrin RS
    Cell Immunol; 1996 Apr; 169(1):85-90. PubMed ID: 8612299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of lymphokine-activated killer activity in T-replete and T-cell-depleted human bone marrow by interleukin 4.
    Drobyski WR; LeFever AV; Truitt RL
    Exp Hematol; 1991 Oct; 19(9):950-7. PubMed ID: 1716592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scanning electron microscopy of multidrug resistant cells in haematological and mammary malignancies.
    Galimberti S; Bianchi F; Bernardini N; Mattii L; Dolfi A; Lupetti M; Petrini M
    Cell Mol Biol (Noisy-le-grand); 1993 Jul; 39(5):543-51. PubMed ID: 8104068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.
    Fairchild CR; Moscow JA; O'Brien EE; Cowan KH
    Mol Pharmacol; 1990 Jun; 37(6):801-9. PubMed ID: 1972772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between multi-drug resistance and resistance to natural-killer-cell and lymphokine-activated killer-cell lysis in human leukemic cell lines.
    Treichel RS; Olken S
    Int J Cancer; 1992 Jan; 50(2):305-10. PubMed ID: 1370437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed acute leukemic cells without changes in drug resistance or in the expression of adhesion molecules.
    Arienti F; Gambacorti-Passerini C; Borin L; Rivoltini L; Orazi A; Pogliani EM; Corneo G; Parmiani G
    Ann Oncol; 1992 Feb; 3(2):155-62. PubMed ID: 1606087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytocidal activity of PBL, LAK, and IDEC-C2B8 and expression of HLA class 1, ICAM-1, and CD20 in vincristine-resistant hematologic cell lines.
    Hirose M; Hamano S; Tobinai K; Kuroda Y
    J Immunother; 1999 May; 22(3):237-44. PubMed ID: 10335483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line.
    Rivoltini L; Colombo MP; Supino R; Ballinari D; Tsuruo T; Parmiani G
    Int J Cancer; 1990 Oct; 46(4):727-32. PubMed ID: 1976601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectors.
    Foa R; Fierro MT; Raspadori D; Bonferroni M; Cardona S; Guarini A; Tos AG; di Celle PF; Cesano A; Matera L
    Blood; 1990 Oct; 76(7):1349-54. PubMed ID: 2207312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered conjugate formation and altered apoptosis of multidrug-resistant human leukemia cell line affects susceptibility to killing by activated natural killer (NK) cells.
    Treichel RS; Bunuan M; Hahn N; Wee K
    Int J Cancer; 2004 Jan; 108(1):78-85. PubMed ID: 14618619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of human natural killer cell activity by recombinant interleukin-2 towards multidrug-resistant human epidermoid carcinoma.
    Ades EW; Bosse D; Pruckler J
    Pathobiology; 1990; 58(2):84-7. PubMed ID: 1972884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic and cytogenetic analysis of atypical multidrug resistance in human leukaemic cells selected with methotrexate at high concentration.
    Kavallaris M; Haber M; Norris MD; Pittman SM; Reed C; Stewart BW
    Cancer Lett; 1990 Jun; 51(3):193-201. PubMed ID: 1972035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation and partial characterization of melanoma sublines resistant to lymphokine activated killer (LAK) cells. Relevance to doxorubicin resistance.
    Rivoltini L; Gambacorti-Passerini C; Supino R; Parmiani G
    Int J Cancer; 1989 May; 43(5):880-5. PubMed ID: 2714894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxicity of artesunic acid homo- and heterodimer molecules toward sensitive and multidrug-resistant CCRF-CEM leukemia cells.
    Horwedel C; Tsogoeva SB; Wei S; Efferth T
    J Med Chem; 2010 Jul; 53(13):4842-8. PubMed ID: 20527917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug-resistant colonic cancer cell line LoVoDx is efficiently killed by lymphokine-activated killer cells from patients with carcinoma of the colon.
    Mooney EF; Dye JF; Guillou PJ; Monson JR
    Br J Surg; 1993 Oct; 80(10):1259-61. PubMed ID: 8242292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of a P-glycoprotein gene is inducible in a multidrug-resistant human leukemia cell line.
    Gekeler V; Frese G; Diddens H; Probst H
    Biochem Biophys Res Commun; 1988 Sep; 155(2):754-60. PubMed ID: 2901835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.